Stop TB Partnership

Coordinating Board appoints new Vice-Chair and members of Executive and Finance Committees


07 October 2013 - Geneva - The Stop TB Partnership Coordinating Board has appointed a new Vice-Chair and members of its Executive and Finance committees.

Dr Joanne Carter, Executive Director of RESULTS has been elected as Vice-Chair and will serve for a period of three years.

Dr Carter has nearly two decades of experience engaging in and leading advocacy efforts to increase resources and political attention for tuberculosis (TB).

She has been engaged with the TB Community and the Stop TB Partnership for many years, most recently providing input to the Executive Committee on the Secretariat’s Operational Strategy. Through her long-term involvement with the Global Fund Board, including as a Board member, Dr Carter has extensive experience working on difference aspects of global public health.

In addition, the following Board members have been appointed to the Executive Committee:

  • Mr Aaron Oxley (Executive Director, Results UK) Developed Country NGO representative
  • Mr Austin Arinye Obiefuna (Executive Director, Afro Global Alliance) Developing Country NGO representative.

The following individuals have been appointed to the newly formed Finance Committee:

  • Mrs Cheri Vincent (Infectious Diseases Division Chief, USAID) as Chair;
  • Mr Prabodh Bhambal (Interim Deputy Executive Director, The Union)- member;
  • Mr Thomas Forisser (Deputy Director, Strategy, Planning and Management for HIV and TB, Bill and Melinda Gates Foundation)- member, and
  • Dr Evan Lee (Vice-President, Global Health Programs and Access, Eli Lilly)- member.

"We are honored to have Dr Joanne Carter join us," said Dr Lucica Ditiu, Executive Secretary of the Stop TB Partnership. "Dr Carter’s focus, experience and passion will be instrumental in taking us forward at this critical time. We would like to congratulate and warmly welcome all the new appointees to the Executive Committee and Finance Committee."

These appointments are the latest step in a series of governance reforms approved by the Coordinating Board at its 22nd meeting in Kuala Lumpur, Malaysia, in November 2012 to improve its performance and its impact on TB.